Truehand Inc’s Pfizer PFE Stock Holding History

Truehand Inc’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$2.41M	Sell	40,804 -2,889	-7%	-$143K	1.41%	27
2021 Q3	$1.88M	Hold	43,693	–	–	1.11%	36
2021 Q2	$1.71M	Hold	43,693	–	–	1.01%	40
2021 Q1	$1.58M	Hold	43,693	–	–	0.97%	40
2020 Q4	$1.61M	Sell	43,693 -2,359	-5%	-$86.5K	1.06%	35
2020 Q3	$1.6M	Sell	46,052 -333	-0.7%	-$11.7K	1.16%	32
2020 Q2	$1.44M	Sell	46,385 -1,056	-2%	-$35.9K	1.11%	34
2020 Q1	$1.47M	Hold	47,441	–	–	1.39%	29
2019 Q4	$1.76M	Sell	47,441 -1,831	-4%	-$65.2K	1.34%	32
2019 Q3	$1.68M	Hold	49,272	–	–	1.31%	34
2019 Q2	$2.02M	Hold	49,272	–	–	1.54%	25
2019 Q1	$1.99M	Hold	49,272	–	–	1.51%	26
2018 Q4	$2.04M	Buy	+49,272	New	+$2.05M	1.73%	20

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Truehand Inc's PFE Position: Q4 2021 in Review

Truehand Inc reduced its Pfizer (PFE) stake by 6.6% in Q4 2021, selling an estimated $143K and leaving 40,804 shares worth $2.41M. The position accounts for 1.41% of the portfolio, ranked #27.

Truehand Inc first reported a position in PFE in Q4 2018 and has held it in 13 quarters since. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

Truehand Inc held 40,804 shares of Pfizer worth $2.41M as of Q4 2021.
Truehand Inc sold 2,889 Pfizer shares in Q4 2021, an estimated $143K.
Pfizer made up 1.41% of Truehand Inc's portfolio in Q4 2021, its #27 holding.
Truehand Inc first reported a position in Pfizer in Q4 2018 and has held it in 13 quarters since.
3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on Truehand Inc's 13F filing for Q4 2021, filed 9 Feb 2022.